Tag: Lupus
Breakthrough Infections in Lupus Patients Down With COVID Booster
Sixty-four percent of those with breakthrough COVID-19 had received booster compared with 82 percent of those without breakthrough infection
Normal-Looking Skin Involved in Cutaneous Lupus Erythematosus
Normal-appearing skin is type I interferon-rich environment; interferon-induced gene expression changes seen in all major skin type cells
Racial Disparities Seen in Adverse Renal Outcomes for Pediatric Lupus
Proportion of admissions with adverse renal outcomes decreased from 2006 to 2019, but racial disparities persisted
ACR: Lupus Patients Can Have Low Immune Response to COVID-19 Vaccines
However, overall disease activity does not appear to change after vaccination
ACR: COVID-19 Vaccine Not Tied to Severe Rheumatic Disease Flares
Seropositivity lags after vaccination in those with rheumatic diseases but improves after second dose
Belimumab Promising in Combination Therapy for Refractory Lupus
Lower serum IgG anti-dsDNA antibody levels seen at 52 weeks with belimumab rather than placebo given after rituximab
Vaccination Rates Low Among Lupus Patients on Medicaid
Acute care use for vaccine-preventable illnesses potentially could be avoided with greater use of outpatient care, vaccination in SLE patients
Mortality Highest for Asians, Hispanic/Latinos With Lupus
Among patients with systemic lupus erythematosus, mortality is increased for minorities, especially Asian, Hispanic/Latina women
Study Estimates Prevalence of Lupus in the U.S.
Prevalence nine times higher for women versus men; rates highest in American Indian/Alaska Natives, Black women
